Vincy Eklöf

1.0k total citations
12 papers, 783 citations indexed

About

Vincy Eklöf is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Vincy Eklöf has authored 12 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Vincy Eklöf's work include Microscopic Colitis (3 papers), Genetic factors in colorectal cancer (3 papers) and Esophageal and GI Pathology (2 papers). Vincy Eklöf is often cited by papers focused on Microscopic Colitis (3 papers), Genetic factors in colorectal cancer (3 papers) and Esophageal and GI Pathology (2 papers). Vincy Eklöf collaborates with scholars based in Sweden. Vincy Eklöf's co-authors include Richard Palmqvist, Sofia Edin, Åke Öberg, Maria L. Wikberg, Martin Rutegård, Anna M. Dahlin, Ida Lundberg, Pontus Karling, Bethany Van Guelpen and Pär Larsson and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Vincy Eklöf

12 papers receiving 776 citations

Peers

Vincy Eklöf
Vincy Eklöf
Citations per year, relative to Vincy Eklöf Vincy Eklöf (= 1×) peers Yanqin Huang

Countries citing papers authored by Vincy Eklöf

Since Specialization
Citations

This map shows the geographic impact of Vincy Eklöf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincy Eklöf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincy Eklöf more than expected).

Fields of papers citing papers by Vincy Eklöf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincy Eklöf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincy Eklöf. The network helps show where Vincy Eklöf may publish in the future.

Co-authorship network of co-authors of Vincy Eklöf

This figure shows the co-authorship network connecting the top 25 collaborators of Vincy Eklöf. A scholar is included among the top collaborators of Vincy Eklöf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincy Eklöf. Vincy Eklöf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Löwenmark, Thyra, Anna Löfgren‐Burström, Carl Zingmark, et al.. (2020). Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer. Scientific Reports. 10(1). 15250–15250. 61 indexed citations
2.
Lundgren, David, Vincy Eklöf, Richard Palmqvist, Johan Hultdin, & Pontus Karling. (2019). Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy. Scandinavian Journal of Gastroenterology. 54(2). 152–157. 46 indexed citations
3.
Karling, Pontus, David Lundgren, Vincy Eklöf, Richard Palmqvist, & Johan Hultdin. (2019). Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin. Scandinavian Journal of Clinical and Laboratory Investigation. 79(5). 341–346. 7 indexed citations
4.
Eklöf, Vincy, Anna Löfgren‐Burström, Carl Zingmark, et al.. (2017). Cancer‐associated fecal microbial markers in colorectal cancer detection. International Journal of Cancer. 141(12). 2528–2536. 154 indexed citations
5.
Lundgren, D. L., Martin Rutegård, Vincy Eklöf, Richard Palmqvist, & Pontus Karling. (2016). Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls. BMC Gastroenterology. 16(1). 139–139. 2 indexed citations
6.
Lundberg, Ida, Sofia Edin, Vincy Eklöf, et al.. (2016). SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer. BMC Cancer. 16(1). 471–471. 85 indexed citations
7.
Ling, Agnes, Ida Lundberg, Vincy Eklöf, et al.. (2015). The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancer. The Journal of Pathology Clinical Research. 2(1). 21–31. 45 indexed citations
8.
Lundberg, Ida, Sofia Edin, Vincy Eklöf, et al.. (2014). SOX2 Expression Is Regulated by BRAF and Contributes to Poor Patient Prognosis in Colorectal Cancer. PLoS ONE. 9(7). e101957–e101957. 51 indexed citations
9.
Eklöf, Vincy, Maria L. Wikberg, Sofia Edin, et al.. (2013). The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer. British Journal of Cancer. 108(10). 2153–2163. 134 indexed citations
10.
Dahlin, Anna M., Richard Palmqvist, Maria L. Henriksson, et al.. (2010). The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status. Clinical Cancer Research. 16(6). 1845–1855. 141 indexed citations
11.
Guelpen, Bethany Van, Anna M. Dahlin, Johan Hultdin, et al.. (2009). One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case–referent study. Cancer Causes & Control. 21(4). 557–566. 33 indexed citations
12.
Eklöf, Vincy, Bethany Van Guelpen, Johan Hultdin, et al.. (2008). The reduced folate carrier (RFC1) 80G>A and folate hydrolase 1 (FOLH1) 1561C>T polymorphisms and the risk of colorectal cancer: A nested case‐referent study. Scandinavian Journal of Clinical and Laboratory Investigation. 68(5). 393–401. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026